Data from studies analyzing vaccination of non-allergic subjects will inform about the IgE sensitization capacity of the vaccines and hence will provide important information for secondary preventive approaches because any boosting of IgE responses in IgE sensitized subjects without clinical symptoms or in subjects with mild allergy would be unintended. The gene discussed is IGHE; the disease is allergic disease.